JENNIFER THOMAS: Open Payments
NPI 1417528373 · LAGRANGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,989 in 92 payments from 10 companies in 2025. Trend: 2023 $1,572 · 2024 $1,389 · 2025 $1,989
Food & beverage: $1,865Education: $123
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 18 | $398 |
| ABBVIE INC. | 19 | $366 |
| Alkermes, Inc. | 14 | $316 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $278 |
| Vanda Pharmaceuticals Inc. | 11 | $186 |
| Neurocrine BioSciences, Inc. | 11 | $186 |
| Otsuka America Pharmaceutical, Inc. | 5 | $101 |
| Lundbeck LLC | 2 | $55 |
| E.R. Squibb & Sons, L.L.C. | 2 | $54 |
| Luye Pharma (USA) Ltd. | 2 | $48 |
Products named: VRAYLAR, CAPLYTA, AUSTEDO XR, ARISTADA, FANAPT, INGREZZA, ABILIFY MAINTENA, LYBALVI.
Industry payments across GA — which companies pay providers there.
